How much is Assembly Biosciences worth in 2026?

Assembly Biosciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Assembly Biosciences raised?

Assembly Biosciences has raised N/A in total funding across 1 funding rounds.

Assembly Biosciences

Drug Discovery

Assembly Biosciences valuation and funding history | Last updated: August 18, 2025 | 1 funding rounds

Current Valuation

N/A

As of August 18, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$175.0M

Last Funding

Aug 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 18, 2025	PIPE	$175.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Assembly Biosciences is currently valued at N/A as of August 18, 2025.

Track Assembly Biosciences Valuation Updates

Get notified when Assembly Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Assembly Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Assembly Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Assembly Biosciences Worth in 2026?

Assembly Biosciences is a leading private company in the Drug Discovery sector. Track Assembly Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Assembly Biosciences Valuation is Determined

Private company valuations like Assembly Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.